{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:09Z","timestamp":1789588389560,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disorder characterized by the proliferation of interstitial fibroblasts and the deposition of extracellular matrix causing impaired gas exchange. Spiruchostatin A (SpA) is a histone deacetylase inhibitor (HDI) with selectivity toward Class I enzymes, which distinguishes it from other nonspecific HDIs that are reported to inhibit (myo)fibroblast proliferation and differentiation. Because the selectivity of HDIs may be important clinically, we postulated that SpA inhibits the proliferation and differentiation of IPF fibroblasts. Primary fibroblasts were grown from lung biopsy explants obtained from patients with IPF or from normal control subjects, using two-dimensional or three-dimensional culture models. The effect of SpA on fibroproliferation in serum-containing medium \u00b1 transforming growth factor (TGF)\u2013\u03b21 was quantified by methylene blue binding. The acetylation of histone H3, the expression of the cell-cycle inhibitor p21waf1, and the myofibroblast markers \u03b1\u2013smooth muscle actin (\u03b1-SMA) and collagens I and III were determined by Western blotting, quantitative RT-PCR, immunofluorescent staining, or colorimetry. SpA inhibited the proliferation of IPF or normal fibroblasts in a time-dependent and concentration-dependent manner (concentration required to achieve 50% inhibition = 3.8 \u00b1 0.4 nM versus 7.8 \u00b1 0.2 nM, respectively; P &amp;lt; 0.05), with little cytotoxicity. Western blot analyses revealed that SpA caused a concentration-dependent increase in histone H3 acetylation, paralleling its antiproliferative effect. SpA also increased p21waf1 expression, suggesting that direct cell-cycle regulation was the mechanism of inhibiting proliferation. Although treatment with TGF-\u03b21 induced myofibroblast differentiation associated with increased expression of \u03b1-SMA, collagen I and collagen III and soluble collagen release, these responses were potently inhibited by SpA. These data support the concept that bicyclic tetrapeptide HDIs merit further investigation as potential treatments for IPF.<\/jats:p>","DOI":"10.1165\/rcmb.2011-0040oc","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T01:32:58Z","timestamp":1326418378000},"page":"687-694","source":"Crossref","is-referenced-by-count":58,"title":["Spiruchostatin A Inhibits Proliferation and Differentiation of Fibroblasts from Patients with Pulmonary Fibrosis"],"prefix":"10.1093","volume":"46","author":[{"given":"Elizabeth R.","family":"Davies","sequence":"first","affiliation":[{"name":"Brooke Laboratory, Clinical and Experimental Sciences, Faculty of Medicine, and"},{"name":"National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Michael","family":"Haitchi","sequence":"additional","affiliation":[{"name":"Brooke Laboratory, Clinical and Experimental Sciences, Faculty of Medicine, and"},{"name":"National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Thatcher","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Pulmonary and Critical Care, University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Sime","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Pulmonary and Critical Care, University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Matthew","family":"Kottmann","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Pulmonary and Critical Care, University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arasu","family":"Ganesan","sequence":"additional","affiliation":[{"name":"School of Chemistry, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Packham","sequence":"additional","affiliation":[{"name":"Cancer Research UK Centre, School of Medicine, Southampton General Hospital, Southampton, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M. A.","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Davies","sequence":"additional","affiliation":[{"name":"Brooke Laboratory, Clinical and Experimental Sciences, Faculty of Medicine, and"},{"name":"National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,5,1]]},"reference":[{"key":"2026021904134344800_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lpm.2009.09.015","article-title":"Epidemiology of interstitial lung diseases","volume":"39","author":"Valeyre","year":"2010","journal-title":"Presse Med"},{"key":"2026021904134344800_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-3-8","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Meltzer","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"2026021904134344800_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"American Thoracic Society\/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias","volume":"165","author":"American Thoracic Society, European Respiratory Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904134344800_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis","volume":"174","author":"Raghu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904134344800_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm.164.6.2001056","article-title":"Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality","volume":"164","author":"King","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904134344800_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1753465810379801","article-title":"The pathogenesis of idiopathic pulmonary fibrosis","volume":"4","author":"Coward","year":"2010","journal-title":"Ther Adv Respir Dis."},{"key":"2026021904134344800_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann Intern Med"},{"key":"2026021904134344800_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/clim.2001.5008","article-title":"Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment","volume":"99","author":"Sime","year":"2001","journal-title":"Clin Immunol"},{"key":"2026021904134344800_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1164\/rccm.2109039","article-title":"The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis","volume":"166","author":"Nicholson","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904134344800_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000137511","article-title":"Assessment of gene transcription demonstrates connection with the clinical course of idiopathic interstitial pneumonia","volume":"76","author":"Golec","year":"2008","journal-title":"Respiration"},{"key":"2026021904134344800_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1165\/ajrcmb.24.5.4333","article-title":"Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression","volume":"24","author":"Ramos","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021904134344800_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/med.20120","article-title":"Chemical regulation of epigenetic modifications: opportunities for new cancer therapy","volume":"28","author":"Zheng","year":"2008","journal-title":"Med Res Rev"},{"key":"2026021904134344800_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"2026021904134344800_bib14","first-page":"637","article-title":"Histone deacetylase inhibitors: apoptotic effects and clinical implications","volume":"33","author":"Emanuele","year":"2008","journal-title":"Int J Oncol"},{"key":"2026021904134344800_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone\u2013deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"2026021904134344800_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J Cell Biochem"},{"key":"2026021904134344800_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1183\/09031936.00084808","article-title":"Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?","volume":"34","author":"Wang","year":"2009","journal-title":"Eur Respir J"},{"key":"2026021904134344800_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bcp.2008.06.004","article-title":"Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A","volume":"76","author":"Crabb","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"2026021904134344800_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem J"},{"key":"2026021904134344800_bib20","author":"Davies"},{"key":"2026021904134344800_bib21","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/ja039258q","article-title":"Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor","volume":"126","author":"Yurek-George","year":"2004","journal-title":"J Am Chem Soc"},{"key":"2026021904134344800_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1242\/jcs.92.3.513","article-title":"A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors","volume":"92","author":"Oliver","year":"1989","journal-title":"J Cell Sci"},{"key":"2026021904134344800_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2026021904134344800_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bbrc.2005.05.117","article-title":"Tissue engineering strategies for cartilage generation: micromass and three dimensional cultures using human chondrocytes and a continuous cell line","volume":"333","author":"Tare","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2026021904134344800_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0040-4039(00)01874-8","article-title":"Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp","volume":"42","author":"Masuoka","year":"2001","journal-title":"Tetrahedron Letter"},{"key":"2026021904134344800_bib26","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1074\/jbc.270.10.4971","article-title":"Potential role of WAF1\/Cip1\/p21 as a mediator of TGF-beta cytoinhibitory effect","volume":"270","author":"Li","year":"1995","journal-title":"J Biol Chem"},{"key":"2026021904134344800_bib27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<512::AID-IJC13>3.0.CO;2-Z","article-title":"TGF-beta\u2013induced cell-cycle arrest through the p21(WAF1\/CIP1)-G1 cyclin\/Cdks-p130 pathway in gastric-carcinoma cells","volume":"83","author":"Yoo","year":"1999","journal-title":"Int J Cancer"},{"key":"2026021904134344800_bib28","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/MCB.19.8.5504","article-title":"Histone deacetylase 1 can repress transcription by binding to Sp1","volume":"19","author":"Doetzlhofer","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2026021904134344800_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1476-4598-9-275","article-title":"Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line","volume":"9","author":"Waby","year":"2010","journal-title":"Mol Cancer"},{"key":"2026021904134344800_bib30","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1172\/JCI117866","article-title":"Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2","volume":"95","author":"Wilborn","year":"1995","journal-title":"J Clin Invest"},{"key":"2026021904134344800_bib31","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1128\/MCB.01776-08","article-title":"Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis","volume":"29","author":"Coward","year":"2009","journal-title":"Mol Cell Biol"},{"key":"2026021904134344800_bib32","doi-asserted-by":"crossref","first-page":"L864","DOI":"10.1152\/ajplung.00128.2009","article-title":"Abrogation of TGF-beta1\u2013induced fibroblast\u2013myofibroblast differentiation by histone deacetylase inhibition","volume":"297","author":"Guo","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026021904134344800_bib33","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/MCB.24.19.8374-8385.2004","article-title":"Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5","volume":"24","author":"Vega","year":"2004","journal-title":"Mol Cell Biol"},{"key":"2026021904134344800_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tig.2004.02.002","article-title":"Cardiac histone acetylation: therapeutic opportunities abound","volume":"20","author":"McKinsey","year":"2004","journal-title":"Trends Genet"},{"key":"2026021904134344800_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(01)00429-4","article-title":"Enzymatic activity associated with Class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT\/N-CoR","volume":"9","author":"Fischle","year":"2002","journal-title":"Mol Cell"},{"key":"2026021904134344800_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4161\/epi.3.6.7273","article-title":"The role of histone deacetylases in prostate cancer","volume":"3","author":"Abbas","year":"2008","journal-title":"Epigenetics"},{"key":"2026021904134344800_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pros.20022","article-title":"Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer","volume":"59","author":"Halkidou","year":"2004","journal-title":"Prostate"},{"key":"2026021904134344800_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0463.2005.apm_04.x","article-title":"Increased expression of histone deacetylase 2 is found in human gastric cancer","volume":"113","author":"Song","year":"2005","journal-title":"Acta Path Microbiol Immunol Scand"},{"key":"2026021904134344800_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10585-007-9131-5","article-title":"Histone deacetylases: target enzymes for cancer therapy","volume":"25","author":"Mottet","year":"2008","journal-title":"Clin Exp Metastasis"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/46\/5\/687\/66898352\/ajrcmb_46_5_687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/46\/5\/687\/66898352\/ajrcmb_46_5_687.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:13:53Z","timestamp":1771492433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/46\/5\/687\/8483579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,1]]},"published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2011-0040oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,5]]},"published":{"date-parts":[[2012,5,1]]}}}